Home › Funds › ABLES, IANNONE, MOORE & ASSOCIATES, INC. › AMGN

ABLES, IANNONE, MOORE & ASSOCIATES, INC. position in AMGN

AMGEN INC · Health Care

ABLES, IANNONE, MOORE & ASSOCIATES, INC. reported holding 2,558 shares of AMGN (AMGEN INC) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.56% of its reported portfolio and ranking #33 among its reported holdings. ABLES, IANNONE, MOORE & ASSOCIATES, INC. has disclosed AMGN holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)2.56K sh
Reported value held$1.08M
Portfolio Weight0.56%
First reportedQ4 2023
Last changeReduce
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How ABLES, IANNONE, MOORE & ASSOCIATES, INC.'s AMGN position evolved

ABLES, IANNONE, MOORE & ASSOCIATES, INC. first disclosed a stake in AMGN in Q4 2023 at 3,395 shares (US$978K). The position peaked in Q3 2024 at 3,364 shares, worth US$1.1M. Across 12 filings, ABLES, IANNONE, MOORE & ASSOCIATES, INC. increased the stake 0 time(s), trimmed it 5 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 2,558 shares valued at US$1.1M — a reduction of -300 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2023 3.40K $977.82K New
Q1 2024 3.40K $965.26K Hold
Q2 2024 3.36K $1.05M Reduce
Q3 2024 3.36K $1.08M Hold
Q4 2024 3.37K $877.04K Hold
Q1 2025 3.36K $1.05M Hold
Q2 2025 3.34K $933.67K Hold
Q3 2025 3.23K $912.63K Reduce
Q4 2025 3.13K $1.03M Reduce
Q1 2026 2.86K $1.01M Reduce
Q2 2026 2.86K $1.04M Hold
Q3 2026 2.56K $1.08M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMGN and 13F data

AMGN (AMGEN INC) is a Health Care company. 32 other funds we track also report a position in AMGN — the largest reported positions include BlackRock Inc (US$17.87B), STATE STREET CORP (US$10.75B), Capital World Investors (US$10.53B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMGN

All AMGN fund holders →

FAQ

How long has ABLES, IANNONE, MOORE & ASSOCIATES, INC. held AMGN?

ABLES, IANNONE, MOORE & ASSOCIATES, INC. has disclosed AMGN holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is ABLES, IANNONE, MOORE & ASSOCIATES, INC.'s current position in AMGN?

As of Q3 2026, ABLES, IANNONE, MOORE & ASSOCIATES, INC. holds 2.56K shares of AMGN (AMGEN INC), valued at $1.08M, representing 0.56% of its reported portfolio and ranking #33.

Has ABLES, IANNONE, MOORE & ASSOCIATES, INC. been buying or selling AMGN?

In the latest 13F filing (Q3 2026), ABLES, IANNONE, MOORE & ASSOCIATES, INC. reduced its position in AMGN. The position peaked in Q3 2024 at 3.36K shares.

Which other funds hold AMGN?

Other major institutional holders of AMGN include BlackRock Inc, STATE STREET CORP, Capital World Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.